Slenyto is a medication specifically designed to manage and treat insomnia in children and adolescents aged between 2 to 18 years. Its active ingredient is melatonin, a hormone naturally produced by the body that plays a crucial role in regulating sleep-wake cycles. Slenyto works by mimicking the effects of natural melatonin, thereby helping to improve sleep onset, duration, and quality in individuals with sleep disorders. It is particularly useful for those who have neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), which are often accompanied by sleep disturbances. Slenyto is available in the form of prolonged-release tablets, allowing for a gradual release of melatonin into the body over time, and it should be used under the guidance of a healthcare professional.